biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years✦05:32 Blood test flagged Alzheimer's-linked memory decline up to 10 years ahead✦05:38 Testosterone showed no clear memory boost after menopause, review finds✦05:36 Scalp gel that aims to wake hair follicles will be tested in 200 women✦05:33 Lilly's experimental weight-loss shot cut sleep apnea breathing pauses✦23:37 One-time gene therapy for severe child epilepsy cut seizures, maker says✦23:33 Alzheimer's drug cut brain plaque but did not slow decline; maker stops it✦23:32 First patient gets Japan's stem-cell treatment for Parkinson's, maker says✦05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years✦05:32 Blood test flagged Alzheimer's-linked memory decline up to 10 years ahead✦05:38 Testosterone showed no clear memory boost after menopause, review finds✦05:36 Scalp gel that aims to wake hair follicles will be tested in 200 women✦05:33 Lilly's experimental weight-loss shot cut sleep apnea breathing pauses✦23:37 One-time gene therapy for severe child epilepsy cut seizures, maker says✦23:33 Alzheimer's drug cut brain plaque but did not slow decline; maker stops it✦23:32 First patient gets Japan's stem-cell treatment for Parkinson's, maker says
← All story threadsSTORY THREAD

Skipping chemotherapy in HER2-positive breast cancer.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 31, 2026
    FIVE-YEAR RESULTS: 92% DID WELL WITHOUT CHEMOMid-stage trial · 356 people

    Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years

    In HER2-positive breast cancer, a type driven by a protein called HER2, patients whose tumors shrank fast on targeted drugs alone skipped chemo, and most stayed free of invasive disease for five years.